MY135982A - Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody - Google Patents

Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody

Info

Publication number
MY135982A
MY135982A MYPI20003637A MY135982A MY 135982 A MY135982 A MY 135982A MY PI20003637 A MYPI20003637 A MY PI20003637A MY 135982 A MY135982 A MY 135982A
Authority
MY
Malaysia
Prior art keywords
treatment
antibody
grade non
hodgkins lymphoma
grade
Prior art date
Application number
Inventor
Christine A White
Antonio Grillo-Lopez
Original Assignee
Idec Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38742401&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY135982(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idec Pharma Corp filed Critical Idec Pharma Corp
Publication of MY135982A publication Critical patent/MY135982A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

THIS INVENTION DISCLOSED METHODS FOR THE TREATMENT OF INTERMEDIATE-AND HIGH-GRADE NON-HODGKINS LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODIES.
MYPI20003637 1999-08-11 2000-08-09 Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody MY135982A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14828699P 1999-08-11 1999-08-11

Publications (1)

Publication Number Publication Date
MY135982A true MY135982A (en) 2008-07-31

Family

ID=38742401

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20003637 MY135982A (en) 1999-08-11 2000-08-09 Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody

Country Status (2)

Country Link
MY (1) MY135982A (en)
TW (1) TWI280137B (en)

Also Published As

Publication number Publication date
TWI280137B (en) 2007-05-01

Similar Documents

Publication Publication Date Title
PT1187632E (en) Treatment with anti-erbb2 antibodies
EP1227836A4 (en) Treatment of intermediate- and high-grade non-hodgkins lymphoma with anti-cd20 antibody
CY1113600T1 (en) COMBINATION TREATMENTS FOR B-CELL LEVELS INCLUDING ANTI-CD20 ADMINISTRATION
IL204031A (en) Use of an anti-cd40 antibody and anti-cd20 antibody for the preparation of medicaments for treating autoimmune diseases
FR12C0004I1 (en)
MXPA03004793A (en) Transgenic transchromosomal rodents for making human antibodies.
ZA200110004B (en) Use of antibodies against CD20 for the treatment of the graft versus host disease.
TR200103756T2 (en) Treatment with humanized anti-ErbB2 antibodies and anti-ErbB2 antibodies.
CY1110759T1 (en) SNOWLINE DIFFERENCES AND THEIR USES
YU9404A (en) Peptide-based multimeric targeted contrast agents
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
MY176959A (en) Humanized antibodies that recognize beta amyloid peptide
RS20060320A (en) Substituted indazole-o-glucosides
MY142777A (en) Substituted indole-o-glucosides
PL371736A1 (en) Method for administering glp-1 molecules
TNSN06133A1 (en) Immunoglobulin variants and uses thereof
UA86042C2 (en) Substituted indazole-o-glucosides
MX2007009908A (en) Methods for treating lymphomas using a combination of a chemotherapeutic agent and il-2 and optionally an anti-cd20 antibody.
TW200528117A (en) Methods and reagents for the treatment of proliferative diseases
WO2003104425A3 (en) Novel stable anti-cd22 antibodies
CY1105980T1 (en) IMPROVED PROCESS FOR THE PREPARATION OF ALPHA-POLYMORPH ELETRIPTANE HYDROBROMATE
TW200510398A (en) Novel compounds
AU2001255537A1 (en) Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
MY135982A (en) Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody
MXPA05009428A (en) Compositions and methods for preventing and treating endotoxin-related diseases and conditions.